Project Details
Description
An open-label, multicenter, Post-Marketing Requirement study to investigate the safety and tolerability of octaplas (TM) in the management of pediatric patients who require therapeutic plasma exchange
| Status | Finished |
|---|---|
| Effective start/end date | 2/20/15 → 1/1/20 |
Funding
- OCTAPHARMA USA, INC.